UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation

Cancer research (Chicago, Ill.), 2001-06, Vol.61 (12), p.4842-4850

2001

Volltextzugriff (PDF)

Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3353-3361

1998

Volltextzugriff (PDF)

BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks

Molecular cell, 2001-02, Vol.7 (2), p.263-272

2001

Volltextzugriff (PDF)

Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer

Journal of clinical oncology, 1996-06, Vol.14 (6), p.1877-1884

1996

Volltextzugriff (PDF)

Brca1 Controls Homology-Directed DNA Repair

Molecular cell, 1999-10, Vol.4 (4), p.511-518

1999

Volltextzugriff (PDF)

Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations

Genes & development, 1998-12, Vol.12 (24), p.3831-3842

1998

Volltextzugriff (PDF)

Double-strand breaks and tumorigenesis

Trends in cell biology, 2001-11, Vol.11 (11), p.S52-S59

2001

Volltextzugriff (PDF)

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification

Journal of clinical oncology, 2001-05, Vol.19 (10), p.2587-2595

2001

Volltextzugriff (PDF)

Targeted Transgenesis

Proceedings of the National Academy of Sciences - PNAS, 1996-08, Vol.93 (17), p.8804-8808

1996

Volltextzugriff (PDF)

Loss of Heterozygosity Induced by a Chromosomal Double-Strand Break

Proceedings of the National Academy of Sciences - PNAS, 1997-08, Vol.94 (17), p.8988-8993

1997

Volltextzugriff (PDF)

A Model for Testing Recombinogenic Sequences in the Mouse Germline

Human molecular genetics, 1996-07, Vol.5 (7), p.875-886

1996

Volltextzugriff (PDF)

Phase I Study of Escalating Doses of Edatrexate in Combination with Paclitaxel in Patients with Metastatic Breast Cancer

Clinical cancer research, 1999-02, Vol.5 (2), p.275-279

1999

Volltextzugriff (PDF)

Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a Phase II randomized trial of adjuvant Dose-dense chemotherapy for women with node-positive breast carcinoma

Clinical cancer research, 2001-12, Vol.7 (12), p.3934-3941

2001

Volltextzugriff (PDF)

Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes

Seminars in oncology, 1995-12, Vol.22 (6 Suppl 15), p.18

1995

Volltextzugriff (PDF)

The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans

Oncogene, 2002-12, Vol.21 (58), p.8994-9007

Moynahan, Mary Ellen

2002

Volltextzugriff (PDF)

Abstract P6-20-03: Tumor epichaperome expression using 124I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-20-03

2019

Volltextzugriff (PDF)

Involvement of Mammalian Mus81 in Genome Integrity and Tumor Suppression

Science (American Association for the Advancement of Science), 2004-06, Vol.304 (5678), p.1822-1826

2004

Volltextzugriff (PDF)

Double-strand breaks and tumorigenesis

Trends in cell biology, 2001-11, Vol.11, p.S52-S59

2001

Volltextzugriff (PDF)

Homologous Recombination between Heterologs during Repair of a Double-Strand Break: Suppression of Translocations in Normal Cells

Annals of the New York Academy of Sciences, 1999-01, Vol.886 (1), p.183-186

1999

Volltextzugriff (PDF)

Abstract S2-07: cfDNA analysis from BOLERO-2 plasma samples identifies a high rate of ESR1 mutations: Exploratory analysis for prognostic and predictive correlation of mutations reveals different efficacy outcomes of endocrine therapy–based regimens

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S2-S2-07

2016

Volltextzugriff (PDF)

Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models

International journal of radiation oncology, biology, physics, 2015-10, Vol.93 (2), p.444-453

2015

Volltextzugriff (PDF)

Abstract PD09-10: DNA Damage and Repair in Mammary Gland Development

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.PD09-10-PD09-10

2012

Volltextzugriff (PDF)

BARD1 Participates with BRCA1 in Homology-Directed Repair of Chromosome Breaks

Molecular and Cellular Biology, 2003-11, Vol.23 (21), p.7926-7936

2003

Volltextzugriff (PDF)

ATP Hydrolysis by Mammalian RAD51 Has a Key Role during Homology-directed DNA Repair

The Journal of biological chemistry, 2002-06, Vol.277 (23), p.20185-20194

2002

Volltextzugriff (PDF)

Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer

Seminars in oncology, 1997-10, Vol.24 (5 Suppl 17), p.S17

1997

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Englisch
(87)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(49)
Humans
(37)
Female
(20)
Animals
(19)
General & Internal Medicine
(17)
Medicine, General & Internal
(17)
Adult
(14)
Biological And Medical Sciences
(14)
Mice
(14)
Oncology
(14)
Middle Aged
(13)
Medical Sciences
(12)
Antineoplastic Agents
(9)
Breast Neoplasms - Drug Therapy
(9)
Cell Biology
(9)
Paclitaxel - Administration & Dosage
(9)
Pharmacology. Drug Treatments
(9)
Chemotherapy
(8)
Dna Damage
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation

Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer

BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks

Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer

Brca1 Controls Homology-Directed DNA Repair

Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations

Double-strand breaks and tumorigenesis

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification

Targeted Transgenesis

Loss of Heterozygosity Induced by a Chromosomal Double-Strand Break

A Model for Testing Recombinogenic Sequences in the Mouse Germline

Phase I Study of Escalating Doses of Edatrexate in Combination with Paclitaxel in Patients with Metastatic Breast Cancer

Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a Phase II randomized trial of adjuvant Dose-dense chemotherapy for women with node-positive breast carcinoma

Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes

The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans

Abstract P6-20-03: Tumor epichaperome expression using 124I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)

Involvement of Mammalian Mus81 in Genome Integrity and Tumor Suppression

Double-strand breaks and tumorigenesis

Homologous Recombination between Heterologs during Repair of a Double-Strand Break: Suppression of Translocations in Normal Cells

Abstract S2-07: cfDNA analysis from BOLERO-2 plasma samples identifies a high rate of ESR1 mutations: Exploratory analysis for prognostic and predictive correlation of mutations reveals different efficacy outcomes of endocrine therapy–based regimens

Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models

Abstract PD09-10: DNA Damage and Repair in Mammary Gland Development

BARD1 Participates with BRCA1 in Homology-Directed Repair of Chromosome Breaks

ATP Hydrolysis by Mammalian RAD51 Has a Key Role during Homology-directed DNA Repair

Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer

Suchergebnisse filtern